Alnylam Pharmaceuticals
(ALNY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -295,017 | -250,943 | -89,225 | -56,868 | -27,182 |
| Depreciation Amortization | 5,468 | 2,600 | 10,229 | 7,602 | 4,838 |
| Accounts receivable | 4,159 | 4,084 | -4,144 | -505 | -356 |
| Accounts payable and accrued liabilities | 121 | -1,379 | 1,832 | -1,336 | 470 |
| Other Working Capital | -14,935 | -5,866 | -8,118 | -6,954 | -5,482 |
| Other Operating Activity | 211,904 | 209,829 | 20,769 | 11,773 | 3,139 |
| Operating Cash Flow | $-88,300 | $-41,675 | $-68,657 | $-46,288 | $-24,573 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -580,915 | -354,392 | -126,499 | -183,425 | -181,871 |
| PPE Investments | -2,240 | -388 | -4,006 | -3,128 | -2,178 |
| Net Acquisitions | -25,000 | -25,000 | N/A | N/A | N/A |
| Investing Cash Flow | $-608,155 | $-379,780 | $-130,505 | $-186,553 | $-184,049 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 739,716 | 734,578 | 202,315 | 193,391 | 182,192 |
| Common Stock Repurchased | -15,703 | -15,703 | -1,389 | -115 | 0 |
| Financing Cash Flow | $724,013 | $718,875 | $200,926 | $193,276 | $182,192 |
| Beginning Cash Position | 53,169 | 53,169 | 51,405 | 51,405 | 51,405 |
| End Cash Position | 80,727 | 350,589 | 53,169 | 11,840 | 24,975 |
| Net Cash Flow | $27,558 | $297,420 | $1,764 | $-39,565 | $-26,430 |
| Free Cash Flow | |||||
| Operating Cash Flow | -88,300 | -41,675 | -68,657 | -46,288 | -24,573 |
| Capital Expenditure | -2,240 | -388 | -4,006 | -3,128 | -2,178 |
| Free Cash Flow | -90,540 | -42,063 | -72,663 | -49,416 | -26,751 |